PokeAcell

PokeAcell is an immunotherapy company with a proprietary technology for personalized T cell therapy of late stage cancer. PokeAcells proprietary technology activate and grow cancer-specific T cells present in patient's own blood and the cells are given back to the patient as fully personalized treatment. The T cell therapy hold the promise of curative treatment in Metastatic Melanoma and Merkel Cell carcinoma – two of the most severe skin cancers today and with potential in several other indications.

papermill medical

abacus medicine a/s

AA Zentivus

AA Zentivus the global pharma industry's innovative and reliable procurement partner. AA Zentivus' attention to service and detail has made us an industry leader. Our core sectors are sourcing and supplying active pharmaceutical ingredients, intermediates and speciality chemicals to pharmaceutical markets globally. We have the strength and extensive supplier base to enable exacting quantities and the highest quality grade products to serve our client base.

Allodynic Therapeutics, LLC

Allodynic Therapeutics is a clinical-stage biopharma company engaged in developing naltrexone-acetaminophen (ALLOD-2) as an oral investigational product for the acute treatment of migraine. Both naltrexone and acetaminophen individually can simultaneously reduce physical and emotional pain, potentially enhancing treatment outcomes. Naltrexone-acetaminophen U.S. patents extend to 2037.